Andrew Fish, executive director of AdvaMedDx, issued the following statement on today’s House Energy & Commerce Health Subcommittee hearing on the regulation of diagnostic tests and laboratory operations:
The Washington Update for CSBA is provided to AZBio Members as an update on issues that affect our industry at the nation’s capitol
AZBio Trailblazers are selected annually and recognized for their leadership in supporting research, education, innovation and the growth of Arizona’s bioscience sector by the Arizona Bioindustry Association.Continue reading
The latest updates from Capitol Hill as provided by BIO and Republic Consulting Group.Continue reading
Steve Ubl, president and CEO of AdvaMed will leave his post at AdvaMed in the fall to serve as president and CEO of PhRMA.
Ubl shared the letter below with the AdvaMed Board of Directors on Friday, September 25, 2015.Continue reading
The latest updates from Capitol Hill as provided by BIO and Republic Consulting Group.
The Safe and Accurate Food Labeling Act will ensure that food labeling in the United States is consistent across state lines and based on sound science. Continue reading
It seems like only yesterday that Congress, the FDA, and industry came together to reauthorize the Medical Device User Fee Agreement (MDUFA III). Now the process begins again as we prepare for MDUFA IV.Continue reading